Systemic cancer therapy with engineered adenovirus that evades innate immunity-Reference-Cited by-同舟云学术

Systemic cancer therapy with engineered adenovirus that evades innate immunity

Published:2020-11-25 Issue:571 Volume:12 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Atasheva Svetlana¹^ORCID,Emerson Corey C.²^ORCID,Yao Jia¹^ORCID,Young Cedrick¹^ORCID,Stewart Phoebe L.²^ORCID,Shayakhmetov Dmitry M.¹³⁴⁵^ORCID

Affiliation:

1. Lowance Center for Human Immunology, Departments of Pediatrics and Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA.

2. Department of Pharmacology and Cleveland Center for Membrane and Structural Biology, Case Western Reserve University, Cleveland, OH 44106, USA.

3. Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30322, USA.

4. Emory Center for Transplantation and Immune-mediated Disorders, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA.

5. Discovery and Developmental Therapeutics Program, Winship Cancer Institute of Emory University, Atlanta, GA 30322, USA.

Abstract

Safe and effective “designer” adenoviruses target tumors after systemic administration.

Funder

NIH Office of the Director

NSF Office of the Director

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference66 articles.

1. Checkpoint inhibitors go viral

2. Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma

3. Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial

4. Control of Early Viral and Bacterial Distribution and Disease by Natural Antibodies

5. Interactions of viruses and the humoral innate immune response

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic delivery of oncolytic herpes virus using CAR-T cells enhances targeting of antitumor immuno-virotherapy;Cancer Immunology, Immunotherapy;2024-07-02

2. Tutorial: design, production and testing of oncolytic viruses for cancer immunotherapy;Nature Protocols;2024-05-20

3. Oncolytic adenovirus encoding apolipoprotein A1 suppresses metastasis of triple-negative breast cancer in mice;Journal of Experimental & Clinical Cancer Research;2024-04-03

4. Adoptive cell therapy for solid tumors beyond CAR-T: Current challenges and emerging therapeutic advances;Journal of Controlled Release;2024-04

5. The Biodistribution of Replication-Defective Simian Adenovirus 1 Vector in a Mouse Model;Viruses;2024-03-31